The online hub for digital CME and CE courses
The ONA Forum consultants answer your questions
View articles about patient-focused care
April 30, 2013
A novel structural and payment-reform system is proposed to foster accountable cancer care, according to a viewpoint piece published online April 29 in JAMA Internal Medicine.
Significant portions of Iowa's population were found to be an excessive distance from full-service cancer care centers, according to a recent study. However, that number drops significantly if visiting consultant clinics in rural hospitals are taken into consideration.
March 25, 2013
Where does the use of specialty pharmacies fit into cancer care?
February 22, 2013
The financial burden of a cancer diagnosis can be significant. Oncology nurses should familiarize themselves with the organizations that can help patients.
February 22, 2013
Families coping with cancer need a break from stress and its impact on their lives. These organizations help them enjoy happy times together.
January 07, 2013
Most men would not have chosen a different treatment even if they had been aware of costs.
New studies reveal important advances in cancer care quality measurement, physician adherence to quality standards, and end-of-life care, while highlighting the overuse of contralateral prophylactic mastectomy.
A new tumor-tracking technique delivers higher levels of radiation to moving tumors while sparing healthy tissue in lung cancer patients. This technique is moving closer to the clinic.
Radiolabeled agents are powerful tools to target and kill cancer cells. Three recent studies explore the benefits of adding radionuclide therapy when treating metastatic cancer.
The cardiotoxicity sometimes seen with doxorubicin may be caused by the effects of chemotherapy on the enzyme topoisomerase-IIβ.
Patients with advanced cancer who discussed end-of-life care with their doctors earlier in the course of their illness had care that was less aggressive in their last month of life and were more likely to use hospice services.
A phase I trial determined that dasatinib 150 mg daily is the optimum dose when dasatinib is combined with paclitaxel and carboplatin to treat patients with advanced or recurrent ovarian cancer.
Language barriers and the immigration status of caregivers appear to impact the care of Hispanic children with cancer and affect the experience of the families within the medical system.
More than a third of the 12.6 million cancer survivors in the United States have physical or mental health-related problems that jeopardize their overall health.
Certain analyses of cancer cells isolated from the blood could guide decisions about the ideal treatment for a patient with metastatic prostate cancer who has stopped responding to initial therapy.
The ancient Chinese medical practice can relieve the symptoms of dry mouth in patients undergoing radiotherapy, according to the largest trial yet to investigate this effect. Radiotherapy for head and neck cancer often produces this unpleasant and distressing side effect because patients' salivary glands are damaged by radiotherapy.
Active surveillance of small kidney masses is a safe and effective alternative to immediate surgery. The overall and cancer specific survival rates are similar for both approaches.
Fit elderly patients with non-small cell lung cancer (NSCLC) should be considered for salvage targeted therapy. Many physicians use age to decide what therapy to give their patients, since validated biomarkers to direct treatment decisions are lacking.
The plasma test VeriStrat can predict response but not survival benefit from erlotinib in patients with advanced non-small cell lung cancer (NSCLC).
A novel method has been developed to determine how ready acute myeloid leukemia (AML) cells are to die. This discovery may help to more effectively choose treatment options for patient with AML.
For female patients with an abnormal breast or cervical cancer screening result, patient navigation services help to decrease the time to diagnosis and helps vulnerable populations get the care they need in a timely manner.
Patients who live in rural areas are more likely to receive late-stage diagnoses and to die from their colon cancer, and less likely to receive an early diagnosis, chemotherapy, or thorough surgical treatment, according to a recent study presented at the 2012 Annual Clinical Congress of the American College of Surgeons.
Greater difficulty exists in finding matched, unrelated donors for nonwhite patients who are candidates for hematopoietic cell transplantation (HCT), according to a study by researchers at the Moffitt Cancer Center.
October 04, 2012
Learn how patients' perceptions of health care can have a significant influence on the effectiveness of cancer care and patient education.
ATA guidelines for well-differentiated thyroid cancer recommend therapeutic neck dissection when the disease is clinically involved or metastatic and prophylactic central neck dissection when tumors are advanced. Nonetheless, though these established guidelines are in place, the surgical management of cervical nodes varies greatly.
October 01, 2012
What is the role of sunitinib malate in the treatment of sarcomas?
In a prospective, interrupted time series study, a best-practice bundle was used to address all areas of central-line care including reducing entries, having aseptic entries, and using aseptic procedures when changing components.
September 11, 2012
Survivors cite lack of cancer expertise, continuity of care as barriers to role of primary care doctors.
August 24, 2012
Vincristine is a vinca alkaloid indicated for the treatment of certain cancers, and may also be used in some combination therapies.
CancerCare, a leading provider of assistance for patients, discusses resources to help oncology nurses provide culturally competent care to patients in the LGBT community.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
| Bone Cancer | Regimens | Drugs |
| Brain Cancer | Regimens | Drugs |
| Breast Cancer | Regimens | Drugs |
| Endocrine Cancer | Regimens | Drugs |
| Gastrointestinal Cancer | Regimens | Drugs |
| Genitourinary Cancer | Regimens | Drugs |
| Gynecologic Cancer | Regimens | Drugs |
| Head and Neck Cancer | Regimens | Drugs |
| Hematologic Cancer | Regimens | Drugs |
| Lung Cancer | Regimens | Drugs |
| Other Cancers | Regimens | |
| Rare Cancers | Regimens | |
| Skin Cancer | Regimens | Drugs |
